Executive Director, Research and Development
Dr Christopher Chan has significant experience in leading and managing pre-clinical research and translational development of scientific programs, asset and pipeline growth, portfolio management, and program commercialization strategy.
Prior to joining BioCurate, Chris worked in both start-up (Pionyr Immunotherapeutics) and small biotechnology (Compugen USA, Inc) companies, and has experience working in science and technology accelerators, incubators, and leading drug development programs that have led to successful venture capital investments, transformational alliances, and acquisition agreements with large pharma. Chris has led first-in-class antibody development programs from target discovery through to IND-enabling activities, which has culminated in IND clearance by the US FDA and the submission and granting of numerous patents.
Chris’ scientific training is as an immunologist with expertise in biologics and protein therapeutics, immuno-oncology, oncology, inflammation, innate myeloid and lymphocyte biology, and T cell biology. Chris completed his PhD in Immunology at Monash University and the Peter MacCallum Cancer Centre in Melbourne, and performed further postdoctoral studies at Oregon Health and Science University in Portland.